Scarring Alopecia: Diagnostic Approach and Treatment
For suspected scarring alopecia, perform scalp examination looking specifically for loss of follicular ostia (the clinical hallmark), obtain a scalp biopsy when diagnosis is uncertain, and initiate early anti-inflammatory treatment with high-potency topical corticosteroids (class III-IV) and/or intralesional triamcinolone acetonide to prevent irreversible hair loss.
Diagnostic Approach
Clinical Examination Priority
The most critical diagnostic feature is loss of follicular ostia (hair follicle openings), which distinguishes scarring from non-scarring alopecia 1. This is your primary clinical marker.
Key examination findings to document:
- Presence or absence of follicular ostia
- Pattern of hair loss (central vs. diffuse vs. patchy)
- Scalp inflammation signs: erythema, scaling, pustules, or perifollicular erythema
- Symptoms: pruritus, burning, tenderness 2
Dermoscopy/Trichoscopy
Use dermoscopy to enhance diagnostic accuracy. Unlike alopecia areata (which shows yellow dots, exclamation mark hairs), scarring alopecias demonstrate loss of follicular openings and fibrotic changes 1.
When to Biopsy
Obtain a scalp biopsy when:
- Clinical diagnosis is uncertain
- Differentiating between subtypes of primary cicatricial alopecia
- Distinguishing early scarring alopecia from non-scarring conditions 2, 1
The biopsy should include both vertical and horizontal sections for optimal histopathologic assessment 3.
Classification Framework
Primary cicatricial alopecias are classified by predominant inflammatory infiltrate 2:
- Lymphocytic: Lichen planopilaris, frontal fibrosing alopecia, discoid lupus erythematosus, central centrifugal cicatricial alopecia
- Neutrophilic: Folliculitis decalvans, dissecting cellulitis
- Mixed: Mixed pattern inflammation
- Nonspecific: Unclear inflammatory pattern
Treatment Approach
Critical Principle
Scarring alopecias are trichologic emergencies 4. Hair loss is permanent and irreversible once scarring occurs. Early aggressive treatment is essential to halt progression—do not expect hair regrowth in already scarred areas 2.
First-Line Anti-Inflammatory Therapy
Initiate immediately upon diagnosis:
- High-potency topical corticosteroids (class III-IV): Apply to affected areas daily 2
- Intralesional triamcinolone acetonide: Inject into active inflammatory areas 2, 5
These treatments apply across most primary cicatricial alopecia subtypes regardless of inflammatory pattern.
Systemic Therapy Selection
Choose based on predominant inflammatory infiltrate and disease severity 2:
For lymphocytic patterns (LPP, FFA, DLE):
- Hydroxychloroquine for lupus-related cases
- Oral corticosteroids for acute flares
- Immunomodulators (mycophenolate mofetil, methotrexate) for refractory cases
For neutrophilic patterns (folliculitis decalvans):
- Oral antibiotics with anti-inflammatory properties (doxycycline, rifampin combinations)
- Isotretinoin for severe cases
For central centrifugal cicatricial alopecia:
- Consider screening for thyroid disease and diabetes 6
- Patients using metformin showed better outcomes 6
Treatment Goals
Your objectives are to 2:
- Stop or delay hair loss progression
- Reduce clinical inflammation
- Alleviate symptoms (pain, pruritus, burning)
- NOT to regrow hair in scarred areas (set realistic expectations)
Critical Prognostic Factors
Worse outcomes associated with:
- Presence of scaling or pustules at presentation 6
- History of thyroid disease 6
- Delayed diagnosis and treatment initiation 4
Better outcomes associated with:
- Natural hairstyles (avoiding traction) 6
- Absence of concurrent thyroid disease 6
- Early intervention before extensive scarring 4
Common Pitfalls to Avoid
Delaying biopsy in uncertain cases: Diagnosis is often delayed because early disease can be subclinical 2. When in doubt, biopsy.
Promising hair regrowth: Once follicles are destroyed and replaced by fibrous tissue, regrowth is impossible. Set realistic expectations from the start 2.
Underestimating psychological impact: Scarring alopecia causes tremendous anxiety and psychosocial stress 4. Offer psychological support and camouflage techniques 2.
Missing systemic associations: Screen for associated conditions, particularly in central centrifugal cicatricial alopecia (thyroid disease, diabetes, uterine fibroids) 6, 7.
Waiting for "definitive" diagnosis before treating: If clinical examination strongly suggests active scarring alopecia, initiate anti-inflammatory treatment while awaiting biopsy results to prevent further irreversible damage.